Results for tag: "Bevespi"

Bevespi is a brand of respiratory drugs used to treat chronic obstructive pulmonary disease (COPD). It is a combination of two long-acting bronchodilators, glycopyrrolate and formoterol fumarate, which work together to relax the muscles in the airways and improve breathing. Bevespi is used to reduce the frequency and severity of COPD symptoms, such as shortness of breath, wheezing, and chest tightness. It is also used to prevent flare-ups of COPD symptoms. Bevespi is available in both an inhaler and a nebulizer solution. Bevespi is a relatively new drug on the market, but it has quickly become a popular treatment option for COPD. It is generally well-tolerated and has fewer side effects than other COPD medications. Bevespi is also more convenient than other treatments, as it only needs to be taken twice a day. Some companies that produce Bevespi include AstraZeneca, Boehringer Ingelheim, and GlaxoSmithKline. Show Less Read more